Skip to main content
. 2019 Mar 31;85(6):1290–1302. doi: 10.1111/bcp.13896

Table 4.

TEAEs occurring in >1 healthy volunteer receiving 15 days of voxelotor or placebo

Voxelotor Placebo
n = 6
Preferred term 300 mg
n = 6
600 mg
n = 6
900 mg
n = 6
All
n = 18
Abdominal pain 0 0 2 (33.3) 2 (11.1) 0
Diarrhoea 0 0 3 (50.0) 3 (16.7) 0
Gastroenteritis 1 (16.7)a 0 1 (16.7)a 2 (11.1) 0
Dizziness 2 (33.3) 0 0 2 (11.1) 0
Headache 1 (16.7)a 0 4 (66.7)a 5 (27.8) 0
a

All AEs were grade 1 except for grade 2 gastroenteritis and grade 2 headache (2 of 4 events, grade 2).